Just a couple of months ago, a 24-year-old from Scottsdale with chronic kidney disease said he thought he found a donor, but ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...